Tate & Lyle opens new manufacturing and research and development facility in Australia
Tate Lyle today announced the opening of a new state-of-the-art manufacturing and research and development facility for its Food Systems business for the Asia Pacific region in Wacol, Queensland which will reinforce its position as a leading ingredient supplier to the food industry.
The new $7m (AUD) facility, which was officially opened by the Queensland Treasurer and Minister for Employment and Economic Development Andrew Fraser, will also serve as Asia-Pacific headquarters for Tate Lyle’s Food Systems business.
Brian Walker, Regional Sales Director of Tate Lyle Food Systems, said: “This facility is part of a global network of development centres and will continue to draw on that international knowledge base. Our R investment is a real strength of the business and provides the basis of strong customer partnerships.
“The new R facility in Queensland is one more example of our commitment to help our customers develop innovative new food products.”
Tate Lyle Food Systems works closely with manufacturers to develop food products which meet changing consumer needs. Its ingredients enable foods to maintain integrity throughout their shelf life, providing healthier products by reducing the fat content, reducing or replacing sugar, or enhancing the fibre content.
Mr Walker said health, wellness and convenience are the big trends in the food industry, but consumers do not want to compromise on taste. This is where Tate Lyle’s expertise is valuable, helping customers develop good tasting healthier products.
“Our facility in Queensland incorporates the latest in innovative design and technology in food hygiene and allergen control. Everything has been designed to have minimal impact on the environment with extensive waste management regimes in place and the best in occupational health and safety for our staff,” Mr Walker said.
Tate Lyle operates through two global business units, Speciality Food Ingredients and Bulk Ingredients, supported by Innovation and Commercial Development. The Group's strategy is to become the leading global provider of Speciality Food Ingredients through a disciplined focus on growth, and by driving the Bulk Ingredients business for sustained cash generation to fuel this growth.
Speciality Food Ingredients include starch-based speciality ingredients (corn-based speciality starches, sweeteners and fibres), no calorie sweeteners (including SPLENDA® Sucralose) and Food Systems which provides blended ingredient solutions. Bulk Ingredients include corn-based bulk sweeteners, industrial starches and fermentation products (primarily acidulants). The co-products from both divisions are primarily sold as animal feed.
Tate Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2013, Tate Lyle sales totalled £3.3 billion. http://www.tateandlyle.com. SPLENDA® is a trademark of McNeil Nutritionals, LLC
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
